| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEXAS INSTRUMENTS INC | Director | Common Stock | 37,101 | $7,543,798 | $203.33 | 27 Jan 2025 | Direct |
| CARDINAL HEALTH INC | Director | Common Shares | 41,631 | $4,457,847 | $107.08 | 09 Nov 2022 | Direct |
| Organon & Co. | Executive Chair, Director | Phantom Stock | 74,030 | $743,258 | $10.04 | 13 Jun 2025 | Direct |
| Solventum Corp | Director | Restricted Stock Units | 0 | $736,239 | $64.11 | 13 May 2025 | Direct |
| Organon & Co. | Executive Chair, Director | Common Stock | 77,869 | $597,418 | $7.67 | 12 Nov 2025 | IRA |
| TEXAS INSTRUMENTS INC | Director | NQ Stock Option (Right to Buy) | 2,551 | $444,129 | $174.10 | 27 Jan 2025 | Direct |
| Solventum Corp | Director | Common Stock | 5,148 | $336,267 | $65.32 | 13 May 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Common Stock | 15,629 | $51,576 | $3.30 | 02 Jan 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 8,000 | $6,320 | $0.7900 | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OGN | Organon & Co. | 12 Nov 2025 | 1 | +$501,755 | 4 | Executive Chair, Director | 13 Nov 2025, 16:05 |
| OGN | Organon & Co. | 13 Jun 2025 | 1 | +$240,000 | 4 | Director | 16 Jun 2025, 17:17 |
| OGN | Organon & Co. | 14 May 2025 | 1 | +$100,591 | 4 | Director | 15 May 2025, 16:09 |
| SOLV | Solventum Corp | 13 May 2025 | 2 | $0 | 4 | Director | 15 May 2025, 16:23 |
| SOLV | Solventum Corp | 30 Apr 2025 | 1 | $0 | 4 | Director | 02 May 2025, 16:34 |
| TXN | TEXAS INSTRUMENTS INC | 27 Jan 2025 | 2 | $0 | 4 | Director | 29 Jan 2025, 16:43 |
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2025 | 2 | $0 | 4 | Director | 06 Jan 2025, 16:19 |
| OGN | Organon & Co. | 07 Jun 2024 | 1 | +$200,000 | 4 | Director | 11 Jun 2024, 15:17 |
| SOLV | Solventum Corp | 13 May 2024 | 2 | $0 | 4 | Director | 15 May 2024, 16:52 |
| SOLV | Solventum Corp | 01 Apr 2024 | 0 | $0 | 3 | Director | 02 Apr 2024, 16:57 |
| TXN | TEXAS INSTRUMENTS INC | 25 Jan 2024 | 2 | $0 | 4 | Director | 29 Jan 2024, 16:37 |
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2024 | 2 | $0 | 4 | Director | 04 Jan 2024, 17:05 |
| RNAC | Cartesian Therapeutics, Inc. | 13 Nov 2023 | 5 | -$114,775 | 4 | Director | 15 Nov 2023, 17:14 |
| TXN | TEXAS INSTRUMENTS INC | 31 Jul 2023 | 5 | -$1,881,060 | 4 | Director | 03 Aug 2023, 13:06 |
| OGN | Organon & Co. | 09 Jun 2023 | 1 | +$200,005 | 4 | Director | 13 Jun 2023, 16:46 |
| TXN | TEXAS INSTRUMENTS INC | 26 Jan 2023 | 2 | $0 | 4 | Director | 30 Jan 2023, 15:55 |
| RNAC | SELECTA BIOSCIENCES INC | 02 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 16:03 |
| CAH | CARDINAL HEALTH INC | 09 Nov 2022 | 1 | $0 | 4 | Director | 10 Nov 2022, 15:25 |
| RNAC | SELECTA BIOSCIENCES INC | 13 Jun 2022 | 1 | +$149,799 | 4 | Director | 15 Jun 2022, 16:16 |
| OGN | Organon & Co. | 10 Jun 2022 | 1 | +$199,994 | 4 | Director | 14 Jun 2022, 19:31 |
| TXN | TEXAS INSTRUMENTS INC | 27 Jan 2022 | 2 | $0 | 4 | Director | 31 Jan 2022, 16:29 |
| RNAC | SELECTA BIOSCIENCES INC | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:32 |
| RNAC | SELECTA BIOSCIENCES INC | 03 Dec 2021 | 1 | +$50,664 | 4 | Director | 06 Dec 2021, 15:25 |
| CAH | CARDINAL HEALTH INC | 11 Nov 2021 | 1 | $0 | 4 | Director | 15 Nov 2021, 07:09 |
| OGN | Organon & Co. | 04 Jun 2021 | 1 | +$651,748 | 4 | Director | 08 Jun 2021, 20:44 |
| OGN | Organon & Co. | 02 Jun 2021 | 0 | $0 | 3 | Director | 02 Jun 2021, 17:53 |